UnitedHealth End Period Cash Flow from 2010 to 2024

UNH Stock  USD 489.03  6.32  1.28%   
UnitedHealth Group's End Period Cash Flow is increasing with slightly volatile movements from year to year. End Period Cash Flow is estimated to finish at about 26.7 B this year. For the period between 2010 and 2024, UnitedHealth Group, End Period Cash Flow quarterly trend regression had mean deviation of  6,209,075,556 and range of 26.6 B. View All Fundamentals
 
End Period Cash Flow  
First Reported
1989-09-30
Previous Quarter
25.4 B
Current Value
32.7 B
Quarterly Volatility
8.9 B
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check UnitedHealth Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among UnitedHealth main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.2 B, Total Revenue of 390.2 B or Gross Profit of 95.5 B, as well as many exotic indicators such as Price To Sales Ratio of 1.17, Dividend Yield of 0.0145 or PTB Ratio of 3.18. UnitedHealth financial statements analysis is a perfect complement when working with UnitedHealth Group Valuation or Volatility modules.
  
This module can also supplement UnitedHealth Group's financial leverage analysis and stock options assessment as well as various UnitedHealth Group Technical models . Check out the analysis of UnitedHealth Group Correlation against competitors.

Latest UnitedHealth Group's End Period Cash Flow Growth Pattern

Below is the plot of the End Period Cash Flow of UnitedHealth Group Incorporated over the last few years. It is UnitedHealth Group's End Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in UnitedHealth Group's overall financial position and show how it may be relating to other accounts over time.
End Period Cash Flow10 Years Trend
Slightly volatile
   End Period Cash Flow   
       Timeline  

UnitedHealth End Period Cash Flow Regression Statistics

Arithmetic Mean13,443,656,667
Geometric Mean9,255,058,613
Coefficient Of Variation56.81
Mean Deviation6,209,075,556
Median10,923,000,000
Standard Deviation7,637,123,614
Sample Variance58325657.1T
Range26.6B
R-Value0.93
Mean Square Error9052636.3T
R-Squared0.86
Slope1,579,867,679
Total Sum of Squares816559199.4T

UnitedHealth End Period Cash Flow History

202426.7 B
202325.4 B
202223.4 B
202121.4 B
202016.9 B
201911 B
201810.9 B

About UnitedHealth Group Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include UnitedHealth Group income statement, its balance sheet, and the statement of cash flows. UnitedHealth Group investors use historical funamental indicators, such as UnitedHealth Group's End Period Cash Flow, to determine how well the company is positioned to perform in the future. Although UnitedHealth Group investors may use each financial statement separately, they are all related. The changes in UnitedHealth Group's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on UnitedHealth Group's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on UnitedHealth Group Financial Statements. Understanding these patterns can help to make the right decision on long term investment in UnitedHealth Group. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
End Period Cash Flow25.4 B26.7 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether UnitedHealth Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of UnitedHealth Group's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unitedhealth Group Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unitedhealth Group Incorporated Stock:

Complementary Tools for UnitedHealth Stock analysis

When running UnitedHealth Group's price analysis, check to measure UnitedHealth Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UnitedHealth Group is operating at the current time. Most of UnitedHealth Group's value examination focuses on studying past and present price action to predict the probability of UnitedHealth Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UnitedHealth Group's price. Additionally, you may evaluate how the addition of UnitedHealth Group to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Fundamental Analysis
View fundamental data based on most recent published financial statements
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Valuation
Check real value of public entities based on technical and fundamental data
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Is UnitedHealth Group's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of UnitedHealth Group. If investors know UnitedHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about UnitedHealth Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.16
Dividend Share
7.52
Earnings Share
16.4
Revenue Per Share
411.257
Quarterly Revenue Growth
0.086
The market value of UnitedHealth Group is measured differently than its book value, which is the value of UnitedHealth that is recorded on the company's balance sheet. Investors also form their own opinion of UnitedHealth Group's value that differs from its market value or its book value, called intrinsic value, which is UnitedHealth Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because UnitedHealth Group's market value can be influenced by many factors that don't directly affect UnitedHealth Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UnitedHealth Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.